Calidi Biotherapeutics (CLDI) Misses Q1 EPS by 43c

Calidi Biotherapeutics (NYSE: CLDI) reported Q1 EPS of ($0.43).

For earnings history and earnings-related data on Calidi Biotherapeutics (CLDI) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Capital One beats Q2 EPS by $1.13 as Discover integration gains pace
• Morgan Stanley sees limited gas regulation impact on utilities